|
(Health-NewsWire.Net, September 05, 2015 ) The global next-generation antibody therapeutics market was worth $1,490.0 million in 2014, and it is expected to grow at a CAGR of 20.9% during 2015-2020. Oncology based next-generation antibody therapeutics dominated the global market in 2014. Whereas, on the basis of technology, the antibody-drug conjugates (ADCs) accounted for the highest share in the global next-generation antibody therapeutics market in the same year. The next-generation antibody therapeutics market is escalating with high growth rate due to several favorable macro-economic factors, including increased R&D activities. In addition, increasing incidence of chronic diseases is also driving the next-generation antibody therapeutics market at a significant rate.
View Full Report with TOC @ http://www.acutemarketreports.com/report/next-generation-antibody-market
Advancements in antibody technology have helped in the development of next-generation antibody therapeutics, such as ADCs and BsAbs, with improved features. Technological advancements in antibody therapeutics have been imparting positive impact on next-generation antibody therapeutics market, as people are increasingly adopting next-generation antibody therapeutics for getting efficient treatment. Next-generation antibody therapeutics market in developing economies, such as Asia-Pacific, Africa, and Latin America, have been growing at a significant pace due to rising economic active population, which is increasing people’s buying power; and increasing awareness for getting effective treatment.
Request a sample of Report @ http://www.acutemarketreports.com/request-free-sample/39744
As a result of high potential of ADC technology, healthcare providers are specifically using ADC technology for the development of next-generation antibody therapeutics for the treatment of cancer. ADCs help in providing targeted therapy with minimum side effects in patients with cancer. The ADCs market, which increased at a CAGR of approximately 87.2% during 2011-2014, also boosted the market for next-generation antibody therapeutics during the period.
The key companies operating in the global next-generation antibody therapeutics market include Kyowa Hakko Kirin Co., Ltd., Dyax Corp., AstraZeneca plc, F.Hoffmann-La Roche Ltd, Bayer AG, Pfizer, Inc., Seattle Genetics, Inc., Bristol-Myers Squibb Company, Takeda Pharmaceuticals Company Limited, and Biogen.
Report Coverage:
Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis.
Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market.
Uncovers potential demands in the market.
Porter analysis identifies competitive forces within the market.
Provides information on the historical and current market size and the future potential of the market.
Scope of Report:
The research offers next-generation antibody therapeutics market size and market forecast for the period 2011 to 2020.
View all reports of this category @ http://www.acutemarketreports.com/category/healthcare-market
GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET
By Therapeutic Area – Oncology and autoimmune/ inflammatory
By Technology – Antibody-drug conjugates (ADCs), Bispecific antibodies, Fc-engineered antibodies, antibody fragments and antibody-like proteins and biosimilar antibody products
By Region – North America, Europe, Asia and Rest of the World
NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BY TECHNOLOGY
Antibody-drug conjugates (ADCs) market breakdown by region
Bispecific antibodies market breakdown by region
Fc-engineered antibodies market breakdown by region
Antibody fragments and antibody-like proteins market breakdown by region
Biosimilar antibody products market breakdown by region
For More about Reports @ http://www.acutemarketreports.com/report/next-generation-antibody-market
About Us:
AcuteMarket Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.
Our market research professionals have detailed knowledge of the publishers and different kinds of reports in their particular business domains. They will guide you in finding the complete range of available market research reports, review the scope and procedure of the research studies that you select, and provide you guidance in order to assist you in taking the correct business decisions related to the purchase of the market research reports.
Contact us:
Acute Market Reports
Mr. Chris Paul
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
Email: sales@acutemarketreports.com
Website: www.acutemarketreports.com
Acute Market Reports
Chris Paul
7755981103
sales@acutemarketreports.com
Source: EmailWire.Com 
|
